No medications are currently approved for the treatment of nonobstructive hypertrophic cardiomyopathy. Could a new drug from Imbria Pharmaceuticals be the first?
Imagers can now identify vulnerable plaques that were once very challenging to find. The next steps include improving the screening process and determining which lesions need to be treated right away.
TAVR may get more attention, but the Ross procedure has also gained significant momentum in recent years. Ismail El-Hamamsy, MD, PhD, detailed his own team's success with the complex procedure.
Mary E. Brunkow, PhD; Fred Ramsdell, PhD; and Shimon Sakaguchi, PhD, MD, will share the 2025 prize for research that has led to new treatments for autoimmune disease and cancer.
Experts are hoping that, by imaging the dinosaur’s shoulder girdle and forelimb, they can create a digital model that could help in determining a T. Rex arm’s range of motion and strength.
Claustrophobic or not, most would choose the radiation-free modality over CT and tend to consider imaging-exam outcomes more worrisome than MRI in and of itself anyway.
A new brain imaging study is giving experts insight into how medication used to treat ADHD works in the brain to soften symptoms associated with the neurological disorder.
New research published in Annals of Rheumatic Diseases and Hypertension examined the impact medications for different non-cardiovascular conditions can have on a patient's heart health.
Common markers of Alzheimer's disease visualized on PET scans of asymptomatic patients might foreshadow the onset of symptoms in the years following their initial discovery.
Researchers have completed a new analysis of the Evolut Pro and Pro+ devices from Medtronic and the Sapien 3 Ultra devices from Edwards Lifesciences, sharing the results in JACC: Cardiovascular Interventions.
A large academic medical center launched a virtual radiology reading room in 2020 to comply with COVID-related social distancing guidelines. Today the room is still something of a hit.
